Augmentation of Venlafaxine with Aripiprazole in a case of treatment-resistant excoriation disorder

Grant A. Turner, Stephanie Sutton, Ashish Sharma

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We present a case of a 21-year-old woman with excoriation disorder that was resistant to currently reported treatment options. Severe lesions were present on multiple sites of her body. The skin picking appeared to be associated with anxiety surrounding her current medical stay and medical condition. The addition of aripiprazole to the venlafaxine she was already taking resulted in resolution of her unconscious picking. This medication combination may be considered by clinicians in the future for treatment-resistant excoriation disorder as its side effect profile is favorable for patients who have failed first-line treatment options. Large-scale studies investigating the use of second generation antipsychotics combined with selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors for the treatment of excoriation disorder is recommended.

Original languageEnglish (US)
Pages (from-to)29-31
Number of pages3
JournalInnovations in Clinical Neuroscience
Volume11
Issue number1-2
StatePublished - Jan 1 2014

Fingerprint

Serotonin Uptake Inhibitors
Therapeutics
Antipsychotic Agents
Anxiety
Skin
Aripiprazole
Venlafaxine Hydrochloride
Unconscious (Psychology)
Serotonin and Noradrenaline Reuptake Inhibitors

Keywords

  • Aripiprazole
  • Excoriation disorder
  • Neurotic excoriations
  • Skin-picking disorder
  • Venlafaxine

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Augmentation of Venlafaxine with Aripiprazole in a case of treatment-resistant excoriation disorder. / Turner, Grant A.; Sutton, Stephanie; Sharma, Ashish.

In: Innovations in Clinical Neuroscience, Vol. 11, No. 1-2, 01.01.2014, p. 29-31.

Research output: Contribution to journalArticle

@article{6a8c08c8bfc64b2da36c8cbda63c2fac,
title = "Augmentation of Venlafaxine with Aripiprazole in a case of treatment-resistant excoriation disorder",
abstract = "We present a case of a 21-year-old woman with excoriation disorder that was resistant to currently reported treatment options. Severe lesions were present on multiple sites of her body. The skin picking appeared to be associated with anxiety surrounding her current medical stay and medical condition. The addition of aripiprazole to the venlafaxine she was already taking resulted in resolution of her unconscious picking. This medication combination may be considered by clinicians in the future for treatment-resistant excoriation disorder as its side effect profile is favorable for patients who have failed first-line treatment options. Large-scale studies investigating the use of second generation antipsychotics combined with selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors for the treatment of excoriation disorder is recommended.",
keywords = "Aripiprazole, Excoriation disorder, Neurotic excoriations, Skin-picking disorder, Venlafaxine",
author = "Turner, {Grant A.} and Stephanie Sutton and Ashish Sharma",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
volume = "11",
pages = "29--31",
journal = "Innovations in Clinical Neuroscience",
issn = "2158-8333",
publisher = "Matrix Medical Communications",
number = "1-2",

}

TY - JOUR

T1 - Augmentation of Venlafaxine with Aripiprazole in a case of treatment-resistant excoriation disorder

AU - Turner, Grant A.

AU - Sutton, Stephanie

AU - Sharma, Ashish

PY - 2014/1/1

Y1 - 2014/1/1

N2 - We present a case of a 21-year-old woman with excoriation disorder that was resistant to currently reported treatment options. Severe lesions were present on multiple sites of her body. The skin picking appeared to be associated with anxiety surrounding her current medical stay and medical condition. The addition of aripiprazole to the venlafaxine she was already taking resulted in resolution of her unconscious picking. This medication combination may be considered by clinicians in the future for treatment-resistant excoriation disorder as its side effect profile is favorable for patients who have failed first-line treatment options. Large-scale studies investigating the use of second generation antipsychotics combined with selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors for the treatment of excoriation disorder is recommended.

AB - We present a case of a 21-year-old woman with excoriation disorder that was resistant to currently reported treatment options. Severe lesions were present on multiple sites of her body. The skin picking appeared to be associated with anxiety surrounding her current medical stay and medical condition. The addition of aripiprazole to the venlafaxine she was already taking resulted in resolution of her unconscious picking. This medication combination may be considered by clinicians in the future for treatment-resistant excoriation disorder as its side effect profile is favorable for patients who have failed first-line treatment options. Large-scale studies investigating the use of second generation antipsychotics combined with selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors for the treatment of excoriation disorder is recommended.

KW - Aripiprazole

KW - Excoriation disorder

KW - Neurotic excoriations

KW - Skin-picking disorder

KW - Venlafaxine

UR - http://www.scopus.com/inward/record.url?scp=84895877639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895877639&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 29

EP - 31

JO - Innovations in Clinical Neuroscience

JF - Innovations in Clinical Neuroscience

SN - 2158-8333

IS - 1-2

ER -